TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic stroke.
Marija Dusanovic PjevicBiljana JekicLjiljana Beslac BumbasirevicLjubica VojvodicTatjana DamnjanovicMilka GrkNela MaksimovicMilica PesicMilica GulicJelena TrickovicKatarina KacarPublished in: Pharmacotherapy (2021)
TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for rtPA-induced hemorrhagic complications after AIS.